IL-17A-producing γδ T cells control pulmonary Mycobacterium abscessus infection in mice.
The findings establish IL-17A+ γδ T cells as a promising therapeutic target for NTM infections, particularly when IFNγ-dependent immunity is compromised, and suggests that anti-IFNγ autoantibodies compromise γδ T cell function.